February 28, 2018
RNAi Therapeutics: From Eureka! Moment to a Potential New Class of Medicines
How far science and technology have come! At Alnylam, we believe we’re on the verge of a landmark moment in medicine and I can’t help but express my...
Read More ›
January 18, 2018
Alnylam Co-Founds UK Biobank Exome Sequencing Consortium (UKB-ESC)
Alnylam and partners announced an agreement with the UK Biobank to form the UK Biobank Exome Sequencing Consortium (UKB-ESC), to sequence all 500,000 exomes...
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site